Primary Patency of Long-Segment Self-Expanding Nitinol Stents in the Femoropopliteal Arteries

Abstract

Midterm restenosis after long-segment femoropopliteal stenting using self-expanding nitinol stents remains a major problem, particularly in patients with diabetes mellitus. The midterm results in nondiabetics are encouraging.